Drug Database
Back to search

Netherlands· NL-eb4f2687f7ee

Amoxicilline/Clavulaanzuur 500/50 PCH, poeder voor oplossing voor injectie

A amoxicillin und beta-lactamase-inhibitor product containing amoxicilline natrium + kaliumclavulanaat, registered in Netherlands by Pharmachemie B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC J01CR02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAmoxicilline/Clavulaanzuur 500/50 PCH…ATCJ01CR02REGISTER NO.NL-eb4f2687f7eePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amoxicilline natrium + kaliumclavulanaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.

Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search amoxicillin und beta-lactamase-inhibitor products by name

Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$5.60
  • ES Spain$4.65
  • CZ Czechia$1.42
  • IT Italy$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
AMOXICILLINE NATRIUM + KALIUMCLAVULANAAT
Manufacturer
Pharmachemie B.V.
Country
Netherlands (NL)
ATC code
J01CR02
ATC class
Amoxicillin und Beta-Lactamase-Inhibitor
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29420

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for amoxicillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amoxicillin und beta-lactamase-inhibitor against other medicinesHow interaction checks work

Amoxicillin und beta-lactamase-inhibitor · interactions on record

24 records

  • 4 severe
  • 17 moderate

Most severe, free to view

  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • LeflunomideL04AK01severe
  • TeriflunomideL04AK02severe

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amoxicillin und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amoxicillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Amcladoz, Amclavu
  • Belgium · Amoclane, Amoclaneeg
  • Bulgaria · Amoksiklav Es, Aмоксигамма
  • Cyprus · Augmentin, Augmentin Es
  • Czechia · Amoksiklav, Amoxicillin/Clavulanic Acid Aptapharma
  • Germany · Amoclan, Amoclav
  • Denmark · Amoxicillin/Clavulansyre Aurobindo, Baxumil
  • Estonia · Amoksiklav, Amoxicillin/Clavulanic Acid Auxilia
  • Spain · Amoxicilina / Ácido Clavulánico Pensa Pharma, Amoxicilina/Ácido Clavulánico Almus
  • Finland · Amorion Comp, Amoxicillin/Clavulanic Acid Bioglan
  • France · Amoxicillin / Clavulanic Acid Reig Jofre, Amoxicillin/Acide Clavulanique Zydus France
  • United Kingdom (Northern Ireland) · Augmentin, Augmentin Duo
  • Greece · Augmentin, Augmentin Mf (Γεύση Φρούτων)
  • Croatia · Amoksicilin/Klavulanska Kiselina Antibiotice, Amoksicilin/Klavulanska Kiselina Aptapharma
  • Hungary · Aksolin, Aktil
  • Ireland · Amoclav, Amoxicillin/Clavulanic Acid Krka
  • Iceland · Amoxicillin/Clavulanic Acid Normon, Spectracillin
  • Italy · Abba, Abioclav
  • Lithuania · Amoksiklav, Amoxicillin/Clavulanic Acid Antibiotice
  • Luxembourg · Amoclane, Amoxiclav
  • Latvia · Amoksiklav, Amoxicillin/Clavulanic Acid
  • Malta · Amoxi-Clavulan, Amoxicillin/Clavulanic Acid Aptapharma
  • Norway · Augmentin, Augmentin Blandet Fruktsmak
  • Poland · Amoclan, Amoksiklav
  • Portugal · Agmalife, Agmalife Bid
  • Romania · Amoksiklav, Amoksiklav Quicktab
  • Sweden · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicillin/Clavulanic Acid Bb
  • Slovenia · Amoksicilin/Klavulanska Kislina Antibiotice, Amoksicilin/Klavulanska Kislina Aptapharma
  • Slovakia · Amoksiklav, Amoksiklav 2 X

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7385e87-59ee-4e1f-98ed-9afe6d71760d
GET /v1/drugs/c7385e87-59ee-4e1f-98ed-9afe6d71760d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29420_smpc.pdf",
  "strength": null,
  "atc_label": "Amoxicillin and beta-lactamase inhibitor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29420",
  "excipients": [
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "AMOXICILLINE NATRIUM",
    "KALIUMCLAVULANAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29420.pdf",
  "authorised_at": "2003/12/30",
  "procedure_number": "NL/H/0371/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29420",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about amoxicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console